Oisin Biotechnologies, Inc. — Form D/A
Oisin Biotechnologies, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2021-05-28. The offering totals $9.5M, of which $9.5M was reported sold. Industry: Other.
Offering
- Filed: 2021-05-28
- Form: D/A
- Accession: 0001801885-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $9.5M
- Amount sold: $9.5M
- Remaining: $57
- Investors: 90
- Date of first sale: 2020-06-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-369506
Issuer
- Name: Oisin Biotechnologies, Inc.
- CIK: 0001801885
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 800 5TH AVENUE, SUITE 4100, SEATTLE, WA, 98104
- Phone: 206-880-1166
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Steve Hilbert | Executive Officer | Seattle, WA |
| John Lewis | Executive Officer | Gibsonia, PA |
| Eric Garcia | Executive Officer | Seattle, WA |
| Matthew Scholz | Director | Seattle, WA |
| Matthew Scholz | Executive Officer | Seattle, WA |
| David Gobel | Director | Seattle, WA |
| Stephen Hilbert | Executive Officer | Seattle, WA |
| Gary Hudson | Director | Seattle, WA |
| Gary Hudson | Executive Officer | Seattle, WA |
| Danjuma Quarless | Director | Seattle, WA |
Other filings by this issuer (4)
More